当前位置:首页 - 行情中心 - 三鑫医疗(300453) - 财务分析 - 利润表

三鑫医疗

(300453)

  

流通市值:26.40亿  总市值:37.77亿
流通股本:3.63亿   总股本:5.20亿

利润表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
一、营业总收入1,300,060,980.74929,961,012.41581,745,548.36272,919,002.98
营业收入1,300,060,980.74929,961,012.41581,745,548.36272,919,002.98
二、营业总成本1,075,802,050.82771,379,171.83482,735,379.56226,181,202.2
营业成本846,499,413.35610,055,871.88386,274,648.27182,146,897.25
税金及附加10,279,830.047,694,731.814,545,601.672,317,186.38
销售费用78,307,179.154,462,350.9432,712,377.2514,156,151.1
管理费用91,406,915.6166,891,055.4143,106,982.4820,639,877.07
研发费用51,065,299.5734,200,080.7818,633,5427,483,945.25
财务费用-1,756,586.85-1,924,918.99-2,537,772.11-562,854.85
其中:利息费用4,519,376.413,786,293.232,395,804.47900,781.76
其中:利息收入6,320,687.895,776,935.615,173,989.61,508,214.77
加:公允价值变动收益1,297,864.37---
加:投资收益9,689,333.52750,267.43447,368.141,069,361.58
资产处置收益161,139.26137,427.55137,427.55-31,061.39
资产减值损失(新)-792,712.81-1,258,534.63-605,446.88-5,736.19
信用减值损失(新)-1,171,170.89-1,787,273.06-1,196,104.91-1,488,588.3
其他收益24,197,230.6214,892,737.0811,084,428.058,511,533.7
营业利润平衡项目0000
四、营业利润257,640,613.99171,316,464.95108,877,840.7554,793,310.18
加:营业外收入1,847,694.052,539,035.451,864,208.76364,206.56
减:营业外支出6,717,575.491,995,232.42519,069.89139,882.42
利润总额平衡项目0000
五、利润总额252,770,732.55171,860,267.98110,222,979.6255,017,634.32
减:所得税费用29,536,336.8519,853,134.2613,665,953.157,350,031.59
六、净利润223,234,395.7152,007,133.7296,557,026.4747,667,602.73
持续经营净利润223,234,395.7152,007,133.7296,557,026.4747,667,602.73
归属于母公司股东的净利润206,633,857.16141,410,327.3789,479,881.444,785,584.88
少数股东损益16,600,538.5410,596,806.357,077,145.072,882,017.85
(一)基本每股收益0.40.270.170.11
(二)稀释每股收益0.40.270.170.11
九、综合收益总额223,234,395.7152,007,133.7296,557,026.4747,667,602.73
归属于母公司股东的综合收益总额206,633,857.16141,410,327.3789,479,881.444,785,584.88
归属于少数股东的综合收益总额16,600,538.5410,596,806.357,077,145.072,882,017.85
公告日期2024-03-232023-10-212023-08-052023-04-27
审计意见(境内)标准无保留意见
TOP↑